Optimizing cell line development (CLD) for next-generation biologics is crucial to meet the rapidly growing demand for novel therapeutic modalities. As the biologics sector evolves, it's imperative to address potential bottlenecks in the development process through strategic enhancements and
The Cell Banking Outsourcing Market is on the brink of a significant upswing, with projections estimating a surge from a robust USD 11.03 billion in 2022 to a staggering USD 33.12 billion by 2029. This exponential growth, driven by an impressive Compound Annual Growth Rate (CAGR) of 17.01%,
The biopharmaceutical industry is on the cusp of a manufacturing evolution, largely due to advancements in analytical technologies. A key player that has emerged in this transformative period is Raman spectroscopy. Renowned for its rapid, nondestructive analysis capabilities, Raman spectroscopy is
The evolution of induced pluripotent stem cell (iPSC) culture is set to be revolutionized with the introduction of AMSBIO's StemFit™ Basic04 CT. This innovative cell culture medium, compliant with Good Manufacturing Practice (GMP) standards, is designed to significantly improve the cultivation and
In the realm of biopharmaceutical manufacturing, the genetic integrity of cell banks is paramount to ensuring the safety and efficacy of biological products. Traditional methods for testing the genetic stability of CHO (Chinese Hamster Ovary) involve a suite of assays, each designed to address
Revolutionizing Cell Culture: AI and Automation Merge The realm of life sciences research has been on the cusp of a paradigm shift with the integration of artificial intelligence (AI) and automation in cell culture technology. Cell culture, central to pathbreaking scientific and therapeutic
